0OR2 Stock Overview
Engages in the management and operation of health establishments.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
LNA Santé SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €25.40 |
| 52 Week High | €32.40 |
| 52 Week Low | €17.12 |
| Beta | 0.72 |
| 1 Month Change | 32.02% |
| 3 Month Change | 12.14% |
| 1 Year Change | -9.11% |
| 3 Year Change | -50.19% |
| 5 Year Change | -44.42% |
| Change since IPO | 49.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0OR2 | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 2.2% | 2.5% | -0.6% |
| 1Y | -9.1% | -22.6% | 6.3% |
Return vs Industry: 0OR2 exceeded the UK Healthcare industry which returned -23.8% over the past year.
Return vs Market: 0OR2 underperformed the UK Market which returned 5.8% over the past year.
Price Volatility
| 0OR2 volatility | |
|---|---|
| 0OR2 Average Weekly Movement | 6.3% |
| Healthcare Industry Average Movement | 6.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.1% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0OR2 has not had significant price volatility in the past 3 months.
Volatility Over Time: 0OR2's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 7,923 | Jean Siret | www.lna-sante.com |
LNA Santé SA engages in the management and operation of health establishments. The company operates retirement homes, medical and rehabilitation care, home hospital, surgery, mental health clinic, and health center. LNA Santé SA was founded in 1990 and is based in Vertou, France.
LNA Santé SA Fundamentals Summary
| 0OR2 fundamental statistics | |
|---|---|
| Market cap | €260.69m |
| Earnings (TTM) | €23.41m |
| Revenue (TTM) | €736.09m |
11.1x
P/E Ratio0.4x
P/S RatioIs 0OR2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0OR2 income statement (TTM) | |
|---|---|
| Revenue | €736.09m |
| Cost of Revenue | €495.00m |
| Gross Profit | €241.09m |
| Other Expenses | €217.68m |
| Earnings | €23.41m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.29 |
| Gross Margin | 32.75% |
| Net Profit Margin | 3.18% |
| Debt/Equity Ratio | 138.7% |
How did 0OR2 perform over the long term?
See historical performance and comparison